William Hausdorff

Dr. Hausdorff has worked on the development, clinical evaluation, registration, implementation and epidemiological assessments of a variety of vaccines over the past 30 years. Since 2018, Dr. Hausdorff has served as the Lead, Public Health Value Propositions for Vaccines at PATH, a global organization that works to accelerate health equity by bringing together public institutions, businesses, social enterprises and investors to solve the world’s most pressing health challenges. Prior to joining PATH, he worked for 12 years at GlaxoSmithKline (GSK) Vaccines, eight years at Wyeth Vaccines and was previously at the U.S. Agency for International Development with the Centers for Disease Control and Prevention. In his roles at GSK Vaccines and Wyeth Vaccines, he was involved in the development of Synflorix® and Prevnar 13®, respectively. Dr. Hausdorff performed his post-doctoral work at Duke University after receiving his PhD in Biology from The Johns Hopkins University/National Institutes of Health and his BA in Biology from Carleton College.